Source: by Emily Wasserman | Apr 25, 2016 8:47am Pfizer ($PFE) has been trying to get the FDA to take the black box warning off its smoking cessation drug, Chantix, after regulators warned that the med could be linked to serious psychiatric side effects. Now, the company is celebrating some…...
![](https://www.qfrsolutions.com/wp-content/uploads/2016/04/MCC-687x370.png)
Merz Pharma Announces New Investment in Cytrellis Biosystems
Source: April 27, 2016 10:40 AM Eastern Daylight Time FRANKFURT AM MAIN & BOSTON--(BUSINESS WIRE)--Merz Pharma has made a strategic venture investment in Cytrellis Biosystems, a US based company developing a new class of non-surgical products to combat sagging skin associated with aging. Merz has joined a growing set of…...
![](https://www.qfrsolutions.com/wp-content/uploads/2017/06/Allerganlogo-880x370.png)
Allergan’s new $85M buyout adds a cosmetic drug to a growing portfolio
Source: FierceBiotech by John Carroll | Apr 21, 2016 5:02pm Allergan is racking up another new deal in the wake of its broken merger with Pfizer. Thursday evening the company announced a deal to buy Boston-based Topokine Therapeutics for $85 million up front. The buyout gives Allergan a late-stage drug…...
![](https://www.qfrsolutions.com/wp-content/uploads/2016/04/UnitedHealthGroup-880x370.jpg)
UnitedHealth’s Optum Targets 75 Markets For Health Center Expansion
Source: Forbes UnitedHealth Group UNH -0.72%, the largest U.S. health insurer, is escalating its already aggressive effort to become a nationwide provider of medical care, targeting 75 markets across the country for expansion via its fast-growing Optum healthcare services unit. It’s a retail approach that includes urgent care centers and…...
![](https://www.qfrsolutions.com/wp-content/uploads/2016/12/Val-880x370.png)
Exclusive: Valeant calls in investment banks to weigh options – sources
Source: Reuters BY OLIVIA ORAN AND CARL O'DONNELL Valeant Pharmaceuticals International Inc (VRX.TO) has brought in investment banks to review its options amid interest from buyout firms and other companies in a number of its businesses, according to people familiar with the matter. While Valeant has not decided to sell…...
![](https://www.qfrsolutions.com/wp-content/uploads/2016/04/Galderma.png)
Galderma Announces U.S. Collaboration in Aesthetics with Mentor Worldwide, LLC
Source: PR Newswire FORT WORTH, Texas, [April 4, 2016] – Galderma, a global leader in medical solutions for skin health, and Mentor Worldwide LLC, a global leader in breast aesthetics and reconstruction, today announced a new nationwide collaboration to partner with surgeons to elevate the patient experience across the companies’…...